📰 Development Generation Efficiency News
Page 2 - Development Generation Efficiency News Today
Fast, Ad-Free News Updates
Stay updated with breaking news from Development Generation Efficiency. Real-time updates on events, politics, business and more.
December 30, 2020
Published: Dec 21, 2020 Autobahn Labs and UCSF will establish new ventures for drug discovery and development PALO ALTO, Calif. and SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with ...
December 22, 2020
Autobahn Collaboration to Accelerate UCSF Innovation from Bench to Bedside By Nicholas Weiler on December 18, 2020 Partnership with Autobahn Labs Aims to Pave Road Through ‘Valley of Death’ Faced by Novel Therapies Through its Office of Innovation Ventures, UC San Francisco has formalized a new strategic collaboration with Autobahn Labs, a “virtual incubator” focused on drug discovery and development, to help move scientific discoveries with therapeutic potential more quickly to market...
December 21, 2020
Share: PALO ALTO, Calif. and SAN FRANCISCO, Dec. 21, 2020 /PRNewswire/ -- Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of scientif...
December 21, 2020
Autobahn Labs announces a strategic drug discovery partnership with UCSF Autobahn Labs, a virtual incubator partnering with top academic and research institutions to catalyze early-stage drug discovery and development, today announced a strategic collaboration with the University of California San Francisco (UCSF). The organizations will partner to identify promising early science with significant therapeutic potential, forming jointly owned ventures to accelerate the translation of scientific ...